RPRX
Royalty Pharma plc · Healthcare
EVP, Research, Investments Marshall Urist sold $726K of Royalty Pharma plc
Sold$726,137
$53.06Price
13,684Shares
−21%Stake
What RPRX did after the filing
- The stock from Mon, May 18 open, $53.04
- +5.2%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Jul 1 close.
Traded Thu, May 14. Filed Fri, May 15, 4:38 PM ET, after the close. Returns use the May 18 open and the Jul 1 close. Not investment advice.